Harvard Bioscience (HBIO) Other Working Capital Changes (2010 - 2026)
Harvard Bioscience's (HBIO) quarterly Other Working Capital Changes came in at $139000.0 in Q1 2026, up 243.3% year-on-year from $40489.5 in Q1 2025, and down 70.92% on a QoQ basis from $478000.0 in Q4 2025.
Harvard Bioscience (HBIO) Other Working Capital Changes (2010 - 2026) Analysis & Trends
Harvard Bioscience (HBIO) has 9 years of Other Working Capital Changes data on file, last reported at $139000.0 in Q1 2026.
- On a quarterly basis, Other Working Capital Changes rose 243.3% year-over-year to $139000.0 in Q1 2026; TTM through Mar 2026 was $75000.0, a 111.05% increase from a year earlier, with the FY2025 full-year figure at -$161000.0, up 77.07% from the prior year.
- Other Working Capital Changes for Q1 2026 stood at $139000.0, down from $478000.0 in the prior quarter.
- Over the last five years, Other Working Capital Changes for HBIO reached as high as $960000.0 in Q2 2023 and fell as low as -$1.7 million in Q3 2024.
- Historically, Other Working Capital Changes has averaged -$288000.0 across 5 years, with a median of -$29000.0 in 2025.
- Across the five-year window, Other Working Capital Changes slumped 988.57% in 2022 and soared 347.0% in 2023, its largest moves.
- Year by year, Other Working Capital Changes stood at -$345000.0 in 2022, then soared by 245.8% to $503000.0 in 2023, then tumbled by 76.74% to $117000.0 in 2024, then surged by 308.55% to $478000.0 in 2025, then slumped by 70.92% to $139000.0 in 2026.
- Per Business Quant data, the three most recent Other Working Capital Changes figures were $139000.0 in Q1 2026, $478000.0 in Q4 2025, and -$234000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn |
| 10 | Harvard Bioscience | 28.05 Mn | 20.96 Mn | 12.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 392,000.00 |
| Mar 31, 2026 | 392,000.00 |
| Mar 31, 2026 | 392,000.00 |
| Dec 31, 2025 | -1.10 Mn |
| Dec 31, 2025 | -1.10 Mn |
| Dec 31, 2025 | -1.10 Mn |
| Sep 30, 2025 | -368,000.00 |
| Sep 30, 2025 | -368,000.00 |
| Sep 30, 2025 | -368,000.00 |
| Jun 30, 2025 | -24,000.00 |
| Jun 30, 2025 | -24,000.00 |
| Jun 30, 2025 | -24,000.00 |
| Mar 31, 2025 | -29,000.00 |
| Mar 31, 2025 | -29,000.00 |
| Mar 31, 2025 | -29,000.00 |
| Dec 31, 2024 | -769,000.00 |
| Dec 31, 2024 | -769,000.00 |
| Dec 31, 2024 | -769,000.00 |
| Sep 30, 2024 | -1.69 Mn |
| Sep 30, 2024 | -1.69 Mn |